| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 56.345 | 313.347 | 343.437 | 326.053 |
| Total Income - EUR | - | - | - | - | - | - | 56.345 | 316.156 | 355.039 | 345.483 |
| Total Expenses - EUR | - | - | - | - | - | - | 3.120 | 52.775 | 44.841 | 48.456 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 53.225 | 263.381 | 310.198 | 297.026 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 52.672 | 260.453 | 307.321 | 252.440 |
| Employees | - | - | - | - | - | - | 1 | 3 | 3 | 2 |
Check the financial reports for the company - Dr. Buduru S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 21 | 1.095 | 1.317 | 73.068 |
| Current Assets | - | - | - | - | - | - | 53.364 | 261.017 | 389.387 | 680.725 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 1.966 |
| Receivables | - | - | - | - | - | - | 0 | 181.334 | 0 | 184.951 |
| Cash | - | - | - | - | - | - | 53.364 | 4.057 | 2.893 | 11.328 |
| Shareholders Funds | - | - | - | - | - | - | 52.713 | 260.502 | 386.299 | 252.521 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 1.129 | 1.987 | 4.731 | 502.268 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Dr. Buduru S.r.l.